comparemela.com

Latest Breaking News On - இணை ப்ரிந்ஸிபல் புலனாய்வாளர் - Page 9 : comparemela.com

Melissa D Avery, PhD, CNM, FACNM, FAAN Named New Editor-in-Chief of the Journal of Midwifery & Women s Health

SILVER SPRING, Md., May 12, 2021 (SEND2PRESS NEWSWIRE) The American College of Nurse-Midwives (ACNM) is pleased to announce that Melissa D. Avery, PhD, CNM, FACNM, FAAN will be the Editor-in-Chief (EIC) of the “Journal of Midwifery & Women’s Health” (JMWH) starting January 1, 2022, succeeding Frances E. Likis, CNM, NP, DrPH, who has served as EIC since 2008. “We look forward to Dr. Avery’s contributions to the Journal, building on its strong foundation and bringing new ideas, skills, and energy,” said ACNM Chief Executive Officer, Katrina H. Holland. Dr. Avery is a Professor in the School of Nursing at the University of Minnesota. Her recent research has examined prenatal care practices to enhance maternal confidence for physiologic labor and birth. She is Co-Principal Investigator on a nationally funded project to develop and implement an interprofessional education curriculum for graduate midwifery students and obstetrics-gynecology residents. Dr. Avery is a past AC

Melissa D Avery, PhD, CNM, FACNM, FAAN Named New Editor-in-Chief of the Journal of Midwifery & Women s Health | U S

Melissa D Avery, PhD, CNM, FACNM, FAAN Named New Editor-in-Chief of the Journal of Midwifery & Women s Health | U S
gjsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gjsentinel.com Daily Mail and Mail on Sunday newspapers.

Navidea Biopharmaceuticals Announces NIH Grant Award to UC San Diego for Clinical Study Evaluating Tc99m Tilmanocept as a Kidney Imaging Agent

Share: Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) ( Navidea or the Company ), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the granting of a National Institutes of Health ( NIH ) award to the University of California San Diego School of Medicine for the proposal entitled, Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept. The award (Project Number: 1R01DK127201-01), from the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH, was granted to Co-Principal Investigators UC San Diego faculty Carl Hoh, MD and David Vera, PhD, of the Department of Radiology, and Charles Ginsberg, MD, MAS, of the Department of Medicine, Division of Nephrology.

UTMB researchers receive $11 3 million grant to study immunopathogenesis of Ebola

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop immune system paralysis, which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread. The research will be led by Co-Principal Investigators Alexander Bukreyev, PhD, of UTMB s Department of Pathology, and Mariano Garcia-Blanco, MD, PhD, Chair of the Biochemistry and Molecular Biology Department. While some might question, Why Ebola now? Dr. Bukreyev explains that, while the COVID-19 pandemic has grabbed headlines and been a primary focus for researchers worldwide for the last 18 months, scientists at UTMB have never stopped working to increase their understanding of Ebola

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.